Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial

Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the CMB305 Phase 1b cancer study is displayed with its study details, including that it was terminated after not meeting its efficacy objective and is no longer recruiting participants.
    Difference
    54%
    Check dated 2026-11-11T16:59:36.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:21:16.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-21T20:39:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T20:26:26.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision advances from v3.7.0 to v3.7.1 while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T20:40:38.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study details with a minimal error page and a Home link. This indicates an access or load issue rather than the trial information.
    Difference
    19%
    Check dated 2026-09-23T20:55:43.000Z thumbnail image

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.